Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-29

Clinical Trial Update: Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating patient satisfaction and preference for Sumavel DosePro in migraine treatment. Results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumavel DosePro (sumatriptan)

Snippet

Sponsor: Zogenix, Inc. | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2011-12-29